All News

How Digital Health Companies Are Navigating The Rough Waters Of Trump Era Healthcare Politics

Todd Hixon ,  CONTRIBUTOR Donald Trump’s election combined with continued Republican control of Congress creates uncertainty for the U.S. health care economy that has no recent parallel. Digital health companies and digital health investors are undeterred. Many push forward by focusing on long-standing patient needs and efficiency challenges that any administration will […]

Paragon 28 announces launch of unprecedented small bone fixation system for foot & ankle-Baby Gorilla Mini Plating System

31 January 2017 ENGLEWOOD, Colo., Jan. 30, 2017 /PRNewswire/ — Since its inception, Paragon 28 has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28 has launched innovative products and instrumentation that help to streamline procedures, allow surgeons flexibility in technique and […]

Intralink-Spine’s Réjuve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study

January 31, 2017 – LEXINGTON, Ky.–(BUSINESS WIRE)– With extremely positive clinical results at the six-month juncture from its early safety and feasibility study in Malaysia, Intralink-Spine, Inc. (ILS) confirms that the Réjuve™ System is now poised to begin its multi-site pivotal study beginning with sites in Southeast Asia. “After a […]

Behind bars for fraud: Neurosurgeon Dr. Aria Sabit receives nearly 20-year prison sentence — 8 key insights

Written by  Megan Wood, Beckers Spine – 10 January 2017 Neurosurgeon Aria Sabit, MD, received a 235-month prison sentence today for fraud, as reported by Medscape. Here are eight things you need to know: Criminal history 1. Dr. Sabit possesses a significant criminal history, dating back to 2010. While practicing at […]

Vizient, Inc. Shares Results of Post-Election Health Care Survey

January 30, 2017 IRVING, Texas–(BUSINESS WIRE)–According to Vizient’s post-election survey of member hospital C-suite and hospital pharmacy executives, more than 90 percent are in favor of keeping the protections afforded to patients with preexisting conditions currently included in the Affordable Care Act (ACA). A top concern for the future is […]

Bioventus Shares 2017 Science Summit Schedule, Enhancements to Bioventus Academy

January 30, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced the dates of its 2017 Advances in Bone Healing Science Summits. Taking place on April 28 at the Grand Hyatt Denver in Denver, CO, on April 28 at the Novotel Schiphol Airport in Amsterdam, and on May […]

Trump signs executive order to slash regulations

By Ayesha Rascoe – Reuters, January 30, 2017 WASHINGTON (Reuters) – President Donald Trump signed an order on Monday that will seek to dramatically pare back federal regulations by requiring agencies to cut two existing regulations for every new rule introduced. “This will be the biggest such act that our […]

$7.82 Billion Foot and Ankle Devices (Prostheses, Bracing and Support Devices and Orthopedic Implants and Devices) Market 2016 – Forecast to 2025

Dublin, Jan. 26, 2017 (GLOBE NEWSWIRE) — Research and Markets has announced the addition of the “Foot and Ankle Devices Market Analysis & Trends – Product (Prostheses, Bracing and Support Devices and Orthopedic Implants and Devices ), Cause of Injury (Neurological Disorders, Trauma and Diabetes) – Forecast to 2025” report […]

Vexim: Amendment of the financial agenda for 2017

Toulouse (France), January 30th, 2017 (8:30AM CET) –VEXIM (FR0011072602 – ALVXM / PEA-PME eligible), a medical device company specializing in the minimally invasive treatment of vertebral fractures, will announce its 2016 Full-Year Results on Wednesday, 22 March, 2017 – before the market opening. The other dates announced on the original […]

SpinalCyte, LLC Enrolls First Patient in Landmark Phase I Human Clinical Trial

January 26, 2017 HOUSTON–(BUSINESS WIRE)–SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on the regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the enrollment of its first patient in a study for the development of CybroCell, the first dermal fibroblast cell product for treatment of […]

© 2024 MedDeviceJobs.com Powered by Careerleaf
v.4.3.2